FDA Reconsiders Decision to Remove Tirzepatide from Shortage List
Here's what LookMeds patients need to know
LookMeds Care Team
Updated:
October 18, 2024
min read
On October 2, 2024, the FDA officially removed tirzepatide from its drug shortage list. However, in response to a recent lawsuit filed by a compounding industry association, the FDA is reconsidering its decision as of October 14, 2024.
While this review is underway, LookMeds is once again able to prescribe and sell compounded tirzepatide, providing our patients with more options for their weight loss treatment.
LookMeds remains dedicated to adhering to all regulatory guidelines, ensuring that our patients receive treatments that meet the highest standards of safety and legality.
LookMeds can now offer compounded tirzepatide following the FDA’s decision to review its removal from the shortage list.
Compounded semaglutide is also available through LookMeds for those seeking a tirzepatide alternative.
LookMeds continues to guide patients through these changes, ensuring access to safe treatment options.
LookMeds will continue to inform patients of any developments in the FDA's review of tirzepatide availability.
Recent Developments on Compounded Tirzepatide Availability
In a significant turn of events, the FDA is now re-evaluating its decision to remove tirzepatide from its drug shortage list. This review was prompted by a lawsuit filed by a compounding industry association, which argued that removing tirzepatide from the list was made without proper consideration of the current market demand and availability.
As a result of this ongoing review, the FDA has temporarily allowed compounding pharmacies to resume manufacturing and selling compounded tirzepatide.
This decision means that LookMeds can once again offer compounded tirzepatide to new and existing patients, providing a cost-effective alternative for those seeking weight loss treatments.
While the FDA's final decision is pending, LookMeds remains fully committed to keeping our patients informed and supported throughout this process. We will continue to monitor the situation closely and adapt our offerings to align with any new regulatory changes that may arise.
Our goal is to ensure that our patients have access to safe and effective treatments, even in the face of evolving guidelines.
What Does This Mean for Compounded Tirzepatide Patients?
For both new and existing LookMeds patients, compounded tirzepatide is once again available due to the FDA's decision to review its earlier removal from the drug shortage list.
If you were previously using compounded tirzepatide, you may continue your treatment as planned. Our Care Team will reach out to guide you through this transition and help you understand your options.
Existing LookMeds patients should continue taking their medication as prescribed while we monitor the FDA's ongoing review process. We are working with our licensed 503B pharmacy partners to ensure a steady supply of compounded tirzepatide.
For new patients, we recommend staying informed about the situation and consulting with our licensed clinicians to determine the best treatment option based on your individual needs.
Whether it's continuing with tirzepatide or switching to alternatives like semaglutide, our team is here to support your weight loss journey.
Your Options Moving Forward
With the FDA's review allowing compounded tirzepatide to be available again, you have several options moving forward:
1. Continue with Compounded Tirzepatide
If you were using compounded tirzepatide previously, you can now continue your treatment through LookMeds. Our Care Team will provide guidance to ensure you have access to the medication you need.
2. Switch to Semaglutide or Other Weight-Loss Medications
Semaglutide remains an effective and available treatment option for weight loss through LookMeds. Our licensed clinicians can help determine the best alternative and dosage for you based on your needs.
3. Consider Name-Brand Tirzepatide
For those who prefer name-brand tirzepatide, like Mounjaro, you can purchase it, but be aware that it may come with higher costs and limited availability due to high demand.
4. Stay Informed
As the situation evolves, it’s important to stay updated on the FDA’s review and any changes that may affect your treatment options. LookMeds is committed to keeping you informed, so don’t hesitate to reach out with any questions.
Challenges You May Face in Getting Tirzepatide Safely
Several challenges may arise for patients affected by these changes:
Tirzepatide Insurance Coverage Challenges
Some insurance providers are dropping coverage for weight loss medications, including tirzepatide, which can lead to higher out-of-pocket costs.
High Cash Prices for Name-Brand Tirzepatide
Without insurance, name-brand tirzepatide medications, such as Mounjaro, can exceed $1,300 per month, making it prohibitively expensive for many patients.
Confusion and Misinformation About Changes to Tirzepatide Availability
You may encounter misleading information online regarding tirzepatide availability. It is essential to verify the legitimacy of any product before purchasing and to rely on trusted sources like LookMeds for accurate updates.
Navigating Transition Options
As patients transition between treatment options, there may be uncertainty about the best course of action. LookMeds' Care Team is here to provide guidance and support during this process.
LookMeds Is Here to Help
At LookMeds, our goal is to support your weight loss journey with trusted, effective treatments.
If you're unsure about your next steps, our team of licensed clinicians is ready to help guide you through your options.
Contact LookMeds with any questions you have regarding the availability of compounded tirzepatide and your treatment options.
Learn more about our weight loss prescriptions or answer a few questions to get started.
